ALNYLAM PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 326-350 of 1,000 matching filings.

Per page
25
Current page
14
SC 13G/A File 005-79884

SEC SCHEDULE 13G

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SCHEDULE 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SEC SCHEDULE 13G

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
31 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
19 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
09 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Dec 2022
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
27 Oct 2022
Reporting date
27 Oct 2022
Next action
Verify source filing
SC 13G File 005-79884

SEC SCHEDULE 13G

Filing date
09 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Aug 2022
Reporting date
22 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 Aug 2022
Reporting date
22 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Aug 2022
Reporting date
03 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Aug 2022
Reporting date
03 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .